Search Results - "VALDEZ SAENZ, ENRIQUE"

Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen by Sharma, Anu, Godina Leiva, Eddison, Kalavalapalli, Srilaxmi, Lomonaco, Romina, Marangi, Stephen A., Valdez Saenz, Enrique, Gonzalez, Maria A., Ortiz Rocha, Andrea, Cuervo Pardo, Nathaly, Rosenberg, Jens, Bedossa, Pierre, Bril, Fernando, Barb, Diana, Cusi, Kenneth

“…Objective The objective of this study was to determine the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) in young compared…”
Get full text

1284-P: Prediabetes with Obesity Is a Major Risk Factor for NAFLD and Liver Fibrosis by GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, SHRESTHA, SULAV, MARANGI, STEPHEN A., CHI, XIAOFEI, KALAVALAPALLI, SRILAXMI, SHETTY, SHWETHA S., ORTIZ ROCHA, ANDREA, VALDEZ SAENZ, ENRIQUE, GONZALEZ, MARIA A., MANSOUR, LYDIA, CALVET, MARIANNA M., BARB, DIANA, MATHEWS, APRIL, SHARMA, ANU, CUSI, KENNETH

“…Clinical practice guidelines suggest that patients with prediabetes (preDM) are at a higher risk of NAFLD and liver fibrosis, among other high-risk groups…”
Get full text

1339-P: Hepatic Steatosis and Fibrosis Are Common in Obese Patients with Type 2 Diabetes Mellitus (T2DM) by VALDEZ SAENZ, ENRIQUE, GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, KALAVALAPALLI, SRILAXMI, MARANGI, STEPHEN A., GONZALEZ, MARIA A., ORTIZ ROCHA, ANDREA, CHI, XIAOFEI, GURKA, MATTHEW J., BARB, DIANA, SHARMA, ANU, CUSI, KENNETH

“…Diabetes is a strong predictor of worse outcomes in nonalcoholic fatty liver disease (NAFLD), such as cirrhosis, CVD, and overall mortality. However, its true…”
Get full text

1367-P: Type 2 Diabetes Mellitus and Obesity Amplifies Nonalcoholic Fatty Liver Disease Risk with Age by SHARMA, ANU, GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, VALDEZ SAENZ, ENRIQUE, ORTIZ ROCHA, ANDREA, GONZALEZ, MARIA A., MARANGI, STEPHEN A., SHRESTHA, SULAV, SHETTY, SHWETHA S., BUDD, JEFFREY T., KALAVALAPALLI, SRILAXMI, BARB, DIANA, CUSI, KENNETH

“…Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent in the general population with multiple known metabolic risk factors. There is…”
Get full text

1366-P: Nonalcoholic Fatty Liver Disease in Young-Onset Type 2 Diabetes Mellitus—A New Epidemic? by SHARMA, ANU, GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, VALDEZ SAENZ, ENRIQUE, ORTIZ ROCHA, ANDREA, MARANGI, STEPHEN A., GONZALEZ, MARIA A., SHRESTHA, SULAV, SHETTY, SHWETHA S., BUDD, JEFFREY T., BARB, DIANA, KALAVALAPALLI, SRILAXMI, CUSI, KENNETH

“…The prevalence of young-onset type 2 diabetes mellitus (YOT2DM), defined as T2DM diagnosed in adults <45 years old, is steadily increasing. Nonalcoholic fatty…”
Get full text

1338-P: Characteristics of Patients with Type 2 Diabetes without Nonalcoholic Fatty Liver Disease (NAFLD) by VALDEZ SAENZ, ENRIQUE, GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, MARANGI, STEPHEN A., KALAVALAPALLI, SRILAXMI, GONZALEZ, MARIA A., CHI, XIAOFEI, ORTIZ ROCHA, ANDREA, MOHSENI, YASMINE, BARB, DIANA, GURKA, MATTHEW J., SHARMA, ANU, CUSI, KENNETH

“…About 70% of patients with type 2 diabetes mellitus (T2DM) have NAFLD which is a risk factor for cirrhosis and hepatocellular carcinoma. Many factors may be…”
Get full text

1342-P: Are Plasma Aminotransferases of Value in Screening Patients with T2DM for NAFLD or Fibrosis? by ORTIZ ROCHA, ANDREA, GODINEZ LEIVA, EDDISON, KALAVALAPALLI, SRILAXMI, LOMONACO, ROMINA, SHETTY, SHWETHA S., MARANGI, STEPHEN A., VALDEZ SAENZ, ENRIQUE, SHRESTHA, SULAV, GONZALEZ, MARIA A., CHI, XIAOFEI, GURKA, MATTHEW J., BARB, DIANA, CUSI, KENNETH

“…The ADA recommends to screen for NASH and liver fibrosis individuals with type 2 diabetes (T2DM), obesity (OB) and/or elevated alanine aminotransferase (ALT)…”
Get full text

1349-P: People with Type 2 Diabetes Have a High Prevalence of Nonalcoholic Steatohepatitis with Significant Fibrosis When Screened by NIS4 or Elastography by KALAVALAPALLI, SRILAXMI, GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, MARANGI, STEPHEN A., VALDEZ SAENZ, ENRIQUE, ORTIZ ROCHA, ANDREA, BUDD, JEFFREY T., MOHSENI, YASMINE, CHUN, KELLY Y., PREZANT, TONI R., CONNELLY, MARGERY A., BARB, DIANA, CUSI, KENNETH

“…Nonalcoholic steatohepatitis (NASH) is a leading cause of cirrhosis. Diagnosis remains challenging as a liver biopsy is usually not feasible. NIS4 is a novel…”
Get full text

1361-P: Patients with Severe Nonalcoholic Steatohepatitis (NASH) Have Profound Insulin Resistance and Lipotoxicity by MARANGI, STEPHEN A., KALAVALAPALLI, SRILAXMI, GODINEZ LEIVA, EDDISON, THOMAIDES-BREARS, HELENA B., DIAMOND, CHARLIE, MOHSENI, YASMINE, GONZALEZ, MARIA A., ORTIZ ROCHA, ANDREA, VALDEZ SAENZ, ENRIQUE, SHRESTHA, SULAV, MANSOUR, LYDIA, SHETTY, SHWETHA S., CALVET, MARIANNA M., LOMONACO, ROMINA, BARB, DIANA, CUSI, KENNETH

“…NASH is the more severe form of nonalcoholic fatty liver disease (NAFLD), prone to advanced fibrosis/cirrhosis. However, the metabolic profile of such patients…”
Get full text

1352-P: Cardiometabolic Risk Factors Superior to FIB4 in Identifying Adults at Risk for NAFLD with Fibrosis by Leiva, Eddison Godinez, Sharma, Anu, Kalavalapalli, Srilaxmi, Rocha, Andrea Ortiz, Saenz, Enrique Valdez, Mohseni, Yasmine, Pardo, Nathaly Cuervo, Rosenberg, Jens T, Grajo, Joseph R, Barb, Diana, Cusi, Kenneth

“…Introduction & Objective: A single effective screening tool for hepatic fibrosis across all age groups is currently lacking. The fibrosis-4 score (FIB-4) is…”
Get full text